Latest Trauma Offering Expands the Utility of DRPx, the Company's High-Value Wrist Fracture Plating System
RENO, NV / ACCESSWIRE / April 19, 2022 / The Orthopaedic Implant Company (OIC) today announced the FDA clearance and commercial launch of the market's first and only high-value dorsal spanning plate. This addition to the company's orthopaedic trauma implant portfolio expands the potential clinical impact of OIC's DRPx wrist fracture plating system, fortifying it as the most comprehensive and value-driven alternative to other premium-priced plating systems currently in use.
Launched in August 2021, DRPx is the only high-value distal radius plating system available in the U.S., supporting a wide array of orthopaedic surgeons' technique preferences while increasing opportunities for significant cost savings to help improve the financial viability of ambulatory surgery centers (ASCs), hospitals and their patients nationwide.
"Procedure volumes for the most common fractures are increasing quickly, so the ongoing challenge for our practice is finding more chances to improve value with those procedures and still uphold our high standards for patient outcomes," said Dr. Peter Howard, M.D., Advanced Surgical Care of Clearwater, LLC, Clearwater, Florida. "The addition of OIC's dorsal spanning plate to their DRPx system immediately allows us to address every indication our patients might face when it comes to wrist fracture care, all while continuing to drastically reduce our implant costs and maintain exceptional clinical outcomes."
OIC's wrist fracture plating system reduces implant costs, on average, by more than 50%1 and provides biomechanical and clinical outcome equivalency in comparison to branded and premium-priced implant systems.
"If we want value-based care to work then implant companies have to play their part," said Itai Nemovicher, President and CEO, Orthopaedic Implant Company. "The reality right now is that ASCs are only being reimbursed at 53% the rate we're seeing with hospitals performing the exact same procedures, so this is where we can make a huge difference for ASCs. Adding the dorsal spanning plate to our DRPx system provides surgeons and facilities with the chance to substantially increase value on a high-volume procedure, streamline operations and get the exact same clinical results they're getting with more expensive implant systems."
DRPx is commercially available in the United States. For more information, please visit www.orthoimplantcompany.com or email info@orthoimplantcompany.com.
1McPhilamy, Austin, et al. "The Clinical and Economic Impact of Generic Locking Plate Utilization at a Level II Trauma Center." Journal of Orthopaedic Trauma, Vol. 30, No. 12 Supplement, Dec 2016
About The Orthopaedic Implant Company
The Orthopaedic Implant Company (OIC) is changing the way orthopaedic implants are delivered and priced. OIC creates better value for the implants known and used every day. The company's dynamic, human-focused strategy begins and ends with prioritizing people, not numbers. The team is comprised of industry experts who bring together decades of combined experience to create change in a healthcare system that must evolve.
Follow OIC on: Twitter, LinkedIn, and Facebook.
Levitate Adam King (260) 408-5383 oic@levitatenow.com
SOURCE: The Orthopaedic Implant Company
View source version on accesswire.com: https://www.accesswire.com/697822/The-Orthopaedic-Implant-Company-Announces-FDA-Clearance-Launch-of-First-and-Only-High-Value-Dorsal-Spanning-Plate
It's important to remember that as we watch the stock market crash and our personal net worth take a big hit. While that has certainly happened, it's important to note that the stock market isn't the economy.
The first half of 2022 has been rocky. But Goldman likes this group to bounce back.
Over the past month, the odds of a home price correction spiked. That's according to an analysis CoreLogic ran for Fortune this week.
When legends speak, people listen – and few investors match the legendary status of Ray Dalio. The founder of Bridgewater Associates has built his firm from a 2-room apartment operation into the world’s largest hedge fund, with more than $150 billion in assets under management, and a net gain exceeding $46 billion. Dalio believes that the next two to four years will see our global economic and political systems change in ways that are unpredictable now. And the key to survival, for investors, ma
Your retirement savings are $1 million. You want $100,000 of yearly retirement income, including Social Security. Is that doable without tons of risk?
(Bloomberg) -- The world’s richest nation is waking up to an unpleasant and unfamiliar sensation: It’s getting poorer.Most Read from BloombergWalmart’s Troubles Should Have Everyone on High AlertA $5 Trillion ‘Wealth Shock’ Is Cracking Americans’ Nest EggsOne of the World’s Frothiest Housing Markets Turned Into a Seller’s Headache OvernightPutin’s War Means Russia’s Rich Aren’t Welcome at Davos AnymoreElon Musk Gets Defensive Over Twitter Meme as Harassment Report SurfacesAmericans’ collective n
The protester revealed the message “Stop raping us” in the blue and yellow colours of the Ukraine flag.
It’s been a terrible week in an awful year for the stock market. Walmart (WMT) Target (TGT) and Tencent (HK:700) each reported disappointing results to add fuel to the worries about interest-rate hikes and quantitative tightening. Over the last six weeks, equity redemptions have totaled $46 billion, versus $91 billion when the COVID outbreak first became apparent, according to Sean Darby, chief equity strategist at Jefferies.
Another week of big losses as Wall Street adjusts to a "hard" reality. Tesla broke decisively, but it wasn't alone.
High-yield dividend stocks have been viewed more favorably than high-multiple growth stocks these days. After yet another month of excessive market-wide selling, the yields of many top dividend stocks are slightly richer. As the Fed raises interest rates further, growth and value could continue to get slammed. This week, the Fed signaled that it's more than willing to keep the rate hikes coming until inflation backs down, even if it means jeopardizing a "soft landing" and inflicting more pain in
(Bloomberg) -- Amazon.com Inc., stuck with too much warehouse capacity now that the surge in pandemic-era shopping has faded, is looking to sublet at least 10 million square feet of space and could vacate even more by ending leases with landlords, according to people familiar with the situation. Most Read from BloombergWalmart’s Troubles Should Have Everyone on High AlertA $5 Trillion ‘Wealth Shock’ Is Cracking Americans’ Nest EggsOne of the World’s Frothiest Housing Markets Turned Into a Seller
“This inflation problem is widespread, it’s persistent and likely to be protracted"
The Dow Jones reversed higher while the S&P 500 battled out of bear market territory. Tesla stock dived amid reports about CEO Elon Musk.
Many tech stocks tumbled over the past few months as rising interest rates and other macroeconomic headwinds sparked a retreat toward more conservative investments. Two of the most resilient names were Apple (NASDAQ: AAPL) and Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL).
Economist Larry Summers was right about inflation last year — so we asked him what he sees coming next for the U.S. economy.
When Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett buys or sells shares of a company, Wall Street and investors tend to pay close attention. Since becoming CEO in 1965, he's overseen the creation of more than $680 billion in shareholder value and delivered an average annual return of 20.1% for Berkshire's Class A (BRK.A) shareholders (himself included).
Musk plans to build a 'hardcore litigation' department after sexual harassment allegations (which he denied).
In this article, we discuss 10 buy-the-dip stocks to buy according to billionaire Ken Fisher. If you want to skip our detailed analysis of Fisher’s stock selection and the current sell-off in tech, go directly to 5 Best Buy-the-Dip Tech Stocks According to Billionaire Ken Fisher. The tech-heavy Nasdaq Composite is down 27% in 2022 […]
An earnings recession is not the biggest threat facing the stock market right now. To show that an earnings recession doesn’t necessarily doom the stock market, consider the S&P 500’s (SPX) quarterly return when its earnings-per-share (EPS) is falling. On average over the past century, according to an analysis conducted by Ned Davis Research, the S&P 500 has performed better when its EPS were lower than a year previously — not higher.
The markets may be in free fall, but a few biotechnology companies had an exceptionally good day. Siga’s stock is up more than 40%; Emergent Biosolutions’s gained nearly 12%, and Tonix Pharmaceuticals, 15%. A few cases of monkeypox have been registered in Europe and North America, far from West and Central Africa where outbreaks typically emerge.